Europe’s Bio-Based Ambition Moves Into Production

EU-backed biorefineries are scaling up, but headline investment figures require closer scrutiny

20 Feb 2026

Europe’s bioeconomy is entering a new phase. After years of pilot projects and technical trials, a wave of advanced biorefineries is moving into full industrial deployment, backed by the Circular Bio-based Europe Joint Undertaking. The shift signals a growing belief that renewable materials can compete in real markets, not just research labs.

In Riga, Latvia, the VIOBOND flagship project is building one of Europe’s first commercial-scale lignin-based resin plants. The facility will transform lignin from wood processing into bio-based resins designed to rival fossil alternatives in construction and furniture. If timelines hold, operations are expected to begin in 2026, marking a milestone for wood-derived chemistry.

Further south, Spain’s SUSTAINEXT project is taking shape in Hervás. There, agricultural sidestreams and botanical feedstocks will be converted into plant-based ingredients for food and animal nutrition. In Baillargues, France, the SCALE project has already inaugurated an industrial microalgae biorefinery producing natural ingredients for nutrition, cosmetics, and feed at volumes above 100 tonnes per year. Together, these facilities illustrate how diverse feedstocks can underpin a new industrial base.

The funding model behind them is equally significant. CBE JU support, often in the tens of millions of euros per flagship, is designed to de-risk first-of-a-kind plants and attract private capital. While the broader program operates with a multibillion-euro budget, publicly available figures do not confirm that these highlighted sites alone exceed €1 billion in combined investment. Capital intensity varies by technology, location, and scale, and disclosures remain project-specific.

The industrial logic is compelling. By turning agricultural and forestry residues into higher-value products, operators create multiple revenue streams and reinforce regional circularity. Yet technology alone will not secure success. Long-term offtake agreements and integration into established supply chains will determine whether these plants can compete consistently on price and performance.

If these flagships deliver on their promises, they will represent more than isolated successes. They will show that Europe’s bio-based transition can move from aspiration to durable commercial reality.